You just read:

Sinobioway Consortium Provides Update on Acquiring Sinovac Biotech (Nasdaq: SVA) at the Purchase Price of $8 Per Share

News provided by

Shandong Sinobioway Biomedicine Co.,Ltd

Sep 29, 2017, 08:00 ET